Form D — Inflammasome Therapeutics, Inc.
0002060536-25-000002 · filed 2025-03-17
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $2,450,172
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Inflammasome Therapeutics, Inc.
- CIK
- 1989925
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 57 CHAPEL ST.
NEWTON, MA 02458 - Phone
- 617-331-1071
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul Ashton · Executive OfficerNewton, MA Find on LinkedIn ↗
-
Jayakrishna Ambati · DirectorNewton, MA Find on LinkedIn ↗
-
Balamurali Ambati · DirectorNewton, MA Find on LinkedIn ↗
-
Joon Lee · DirectorNewton, MA Find on LinkedIn ↗
-
Mary Weber · DirectorNewton, MA Find on LinkedIn ↗
-
Napoleone Ferrara · DirectorNewton, MA Find on LinkedIn ↗
View original on SEC EDGAR.